Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors

Vinod D. Jadhav, Adam S. Duerfeldt, Brian S.J. Blagg

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Bicyclic radester analogues have been synthesized and evaluated for Hsp90 inhibitory activity. These analogues induce concentration-dependent degradation of Hsp90-dependent client proteins with the six-membered bicyclic analogues manifesting increased activity versus the five-membered counterparts.

Original languageEnglish (US)
Pages (from-to)6845-6850
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number24
DOIs
StatePublished - Dec 15 2009
Externally publishedYes

Bibliographical note

Funding Information:
The authors gratefully acknowledge NIH/NCI CA 109265, the Madison and Lila Self Graduate Fellowship (A.S.D.) and the American Foundation of Pharmaceutical Education for financial support (A.S.D.).

Keywords

  • Anti-cancer
  • Geldanamycin
  • Hsp90
  • Radicicol

Fingerprint

Dive into the research topics of 'Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors'. Together they form a unique fingerprint.

Cite this